Literature DB >> 23398153

Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Ming Chang Hu1, Kazuhiro Shiizaki, Makoto Kuro-o, Orson W Moe.   

Abstract

The metabolically active and perpetually remodeling calcium phosphate-based endoskeleton in terrestrial vertebrates sets the demands on whole-organism calcium and phosphate homeostasis that involves multiple organs in terms of mineral flux and endocrine cross talk. The fibroblast growth factor (FGF)-Klotho endocrine networks epitomize the complexity of systems biology, and specifically, the FGF23-αKlotho axis highlights the concept of the skeleton holding the master switch of homeostasis rather than a passive target organ as hitherto conceived. Other than serving as a coreceptor for FGF23, αKlotho circulates as an endocrine substance with a multitude of effects. This review covers recent data on the physiological regulation and function of the complex FGF23-αKlotho network. Chronic kidney disease is a common pathophysiological state in which FGF23-αKlotho, a multiorgan endocrine network, is deranged in a self-amplifying vortex resulting in organ dysfunction of the utmost severity that contributes to its morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398153      PMCID: PMC3770142          DOI: 10.1146/annurev-physiol-030212-183727

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  177 in total

1.  Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23.

Authors:  Xijie Yu; Omar A Ibrahimi; Regina Goetz; Fuming Zhang; Siobhan I Davis; Holly J Garringer; Robert J Linhardt; David M Ornitz; Moosa Mohammadi; Kenneth E White
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

Review 2.  Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.

Authors:  David J A Goldsmith; John Cunningham
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

3.  Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.

Authors:  Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias E Larsson; Peyman Björklund
Journal:  Kidney Int       Date:  2010-08-04       Impact factor: 10.612

4.  Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.

Authors:  Ricardo Villa-Bellosta; Víctor Sorribas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-12       Impact factor: 8.311

5.  Serum FGF23 levels in normal and disordered phosphorus homeostasis.

Authors:  Thomas J Weber; Shiguang Liu; Olafur S Indridason; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

6.  Phosphorus binders and survival on hemodialysis.

Authors:  Tamara Isakova; Orlando M Gutiérrez; Yuchiao Chang; Anand Shah; Hector Tamez; Kelsey Smith; Ravi Thadhani; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

7.  Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure.

Authors:  Shinji Ito; Toshihiko Fujimori; Yoshihide Hayashizaki; Yo-ichi Nabeshima
Journal:  Biochim Biophys Acta       Date:  2002-07-19

8.  Renal toxicity of phosphate in rats.

Authors:  L L Haut; A C Alfrey; S Guggenheim; B Buddington; N Schrier
Journal:  Kidney Int       Date:  1980-06       Impact factor: 10.612

9.  Calcium deficiency reduces circulating levels of FGF23.

Authors:  María E Rodriguez-Ortiz; Ignacio Lopez; Juan R Muñoz-Castañeda; Julio M Martinez-Moreno; Alan Peralta Ramírez; Carmen Pineda; Antonio Canalejo; Philippe Jaeger; Escolastico Aguilera-Tejero; Mariano Rodriguez; Arnold Felsenfeld; Yolanda Almaden
Journal:  J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 10.121

Review 10.  The contribution of bone to whole-organism physiology.

Authors:  Gérard Karsenty; Mathieu Ferron
Journal:  Nature       Date:  2012-01-18       Impact factor: 69.504

View more
  205 in total

1.  Randomized trial of intravenous iron-induced hypophosphatemia.

Authors:  Myles Wolf; Glenn M Chertow; Iain C Macdougall; Robert Kaper; Julie Krop; William Strauss
Journal:  JCI Insight       Date:  2018-12-06

2.  Hunt for the culprit of cardiovascular injury in kidney disease.

Authors:  Christian Faul; Myles Wolf
Journal:  Cardiovasc Res       Date:  2015-09-22       Impact factor: 10.787

3.  Phosphorus.

Authors:  Mona S Calvo; Christel J Lamberg-Allardt
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

Review 4.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

5.  Research advances in metabolism 2016.

Authors:  Nikolaos Perakakis; Olivia M Farr; Dario Tuccinardi; Jagriti Upadhyay; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-11-06       Impact factor: 8.694

6.  Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Authors:  Giovanni Tripepi; Barbara Kollerits; Daniela Leonardis; Mahamut Ilker Yilmaz; Maurizio Postorino; Danilo Fliser; Francesca Mallamaci; Florian Kronenberg; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

Review 7.  Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters.

Authors:  Ming Chang Hu; Mingjun Shi; Orson W Moe
Journal:  Pflugers Arch       Date:  2018-12-01       Impact factor: 3.657

Review 8.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

9.  Peripheral levels of the anti-aging hormone Klotho in patients with depression.

Authors:  Alexander Sartorius; Maria Gilles; Anna-Maria Pfeifer; Michael Deuschle; Carolin Hoyer; Dieter Haffner; Maren Leifheit-Nestler; Laura Kranaster
Journal:  J Neural Transm (Vienna)       Date:  2019-05-04       Impact factor: 3.575

Review 10.  Fibroblast growth factor 23 and acute kidney injury.

Authors:  Javier A Neyra; Orson W Moe; Ming Chang Hu
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.